Sleep apnea affects nearly 39 million people in the United States, with many more potentially undiagnosed due to the traditional requirement of a clinical sleep study. However, new options are ...
At-home sleep tests are convenient and cheaper than lab studies. But there are some major differences you should know before buying. Taylor Leamey Former Senior Writer Taylor Leamey wrote about all ...
NORTH PHILADELPHIA (WPVI) -- Few things are as precious as a good night's sleep. People who snore, gasp, or stop breathing may fear overnight testing in a sleep lab. There's been a revolution in ...
At-home sleep tests are devices used to screen for sleep apnea. But getting one isn’t as easy as adding it to your cart. You need to talk to your doctor. Taylor Leamey wrote about all things wellness ...
ATLANTA, Ga., June 17, 2025 /PRNewswire/ -- Huxley Medical, a commercial-stage medical technology firm focused on streamlining detection of sleep and heart disorders, announced that the clinical ...
Home CPAP device maker Resmed is launching a small, disposable wearable to help diagnose cases of obstructive sleep apnea. The NightOwl testing device, about the size of a quarter, is worn on the user ...
SAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced its home ...
(RTTNews) - ResMed Inc.(RMD), announced Thursday that its NightOwl home sleep apnea test or HSAT is now available across the United States, providing a simple and effective at-home diagnostic solution ...
NAMUR, Belgium--(BUSINESS WIRE)--Belgium-based scale-up, Sunrise, announced today the U.S. Food and Drug Administration (FDA) has cleared for use its second generation at-home sleep apnea test that ...
Acurable, a U.K.-based medical device company, announced it raised €11 million ($10.8 million) in a Series A funding round led by Kibo Ventures. Mundi Ventures, Comprador Holdings and Kindred Capital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results